In the BioHarmony Drug Report Database
Anturane (sulfinpyrazone) is a small molecule pharmaceutical. Sulfinpyrazone was first approved as Anturane on 1982-01-01. It is used to treat angina pectoris, coronary disease, gout, and myocardial infarction in the USA. The pharmaceutical is active against solute carrier family 22 member 12. In addition, it is known to target fMet-Leu-Phe receptor.
Image (chem structure or protein)